~~<i id='FFD364162D'><strike id='FFD364162D'><tt id='FFD364162D'><pre id='FFD364162D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

entertainment

author：comprehensive 2025-09-06 03:30:47 - browse：5

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： How to make the FDA’s new prescription one

focus

knowledge

Wikipedia

hotspot

focus

hotspot

JustdaysaftertheendofRoev.Wade,CaitlinBernard,anOB-GYNinIndiana,toldtheIndianapolisStaraheartbreakin

WSS

Artificial intelligence advances fuel industry trying to preserve loved ones after death

Diverse clinical trials: Why aren’t we there yet?

How medical schools plan to diversify without affirmative action

Walmart eyes Medicare Advantage provider ChenMed

White House touts steps to stem shortages of cancer treatments

CDC backtracks, saying fully vaccinated people can go maskless indoors

focus

entertainment

focus

United colonoscopy coverage change 'may cost lives,' doctors say

White House launches permanent pandemic office

Malaria cases in Florida and Texas: Here’s what you need to know

Court strikes down limits on filming of police in Arizona

In Memoriam: Notable people who died in 2023

Russian special forces kill a gunman who broke into a private house near Moscow

Alkermes shareholders re

Body of missing toddler recovered in Delaware River days after flood: Police

How to save PrEP access — and even expand it

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

knowledge

FDA proposes changes to key medical devices approval pathway

Caitlin Bernard's story shows physicians can't shy from advocacy

White House touts steps to stem shortages of cancer treatments

Regeneron agrees to White House price limits on anti

In new study, freeze

Artificial intelligence advances fuel industry trying to preserve loved ones after death

Wikipedia

hotspot

focus

hotspot